We are committed to caring for your pet – while maintaining the highest level of safety for our Associates and pet owners. We thank you for your continued patience and support. Learn more about our COVID-19 response and guidelines.
Read More

Philip J. Bergman, Director of Clinical Studies

DVM, MS, PhD, Diplomate ACVIM (Oncology)

Dr. Bergman is the Director of Clinical Studies for VCA.  He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center and the principal veterinary investigator for the canine melanoma vaccine (Oncept®), which was fully licensed in 2009.  

Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011. From 1999 – 2007 he was the head of the Donaldson-Atwood Cancer Center of The Animal Medical Center in New York.  

After finishing veterinary school from Colorado State University (CSU) in 1990, he was an intern at Kansas State University (‘90-‘91) and returned to CSU for his medical oncology residency (‘91-‘94). Dr. Bergman then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston, Texas (‘94-‘99).  He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.

 
Loading... Please wait